164 related articles for article (PubMed ID: 16610016)
1. Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas.
Liu YC; Shen CY; Wu HS; Hsieh TY; Chan DC; Chen CJ; Yu JC; Yu CP; Harn HJ; Chen PJ; Hsieh CB; Chen TW; Hsu HM
World J Gastroenterol; 2006 Apr; 12(14):2168-73. PubMed ID: 16610016
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene.
Cheng CW; Wu PE; Yu JC; Huang CS; Yue CT; Wu CW; Shen CY
Oncogene; 2001 Jun; 20(29):3814-23. PubMed ID: 11439345
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
Machado JC; Oliveira C; Carvalho R; Soares P; Berx G; Caldas C; Seruca R; Carneiro F; Sobrinho-Simöes M
Oncogene; 2001 Mar; 20(12):1525-8. PubMed ID: 11313896
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
Corso G; Carvalho J; Marrelli D; Vindigni C; Carvalho B; Seruca R; Roviello F; Oliveira C
J Clin Oncol; 2013 Mar; 31(7):868-75. PubMed ID: 23341533
[TBL] [Abstract][Full Text] [Related]
5. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.
Sudo M; Chong JM; Sakuma K; Ushiku T; Uozaki H; Nagai H; Funata N; Matsumoto Y; Fukayama M
Int J Cancer; 2004 Mar; 109(2):194-9. PubMed ID: 14750169
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
[TBL] [Abstract][Full Text] [Related]
8. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.
Oliveira C; Sousa S; Pinheiro H; Karam R; Bordeira-Carriço R; Senz J; Kaurah P; Carvalho J; Pereira R; Gusmão L; Wen X; Cipriano MA; Yokota J; Carneiro F; Huntsman D; Seruca R
Gastroenterology; 2009 Jun; 136(7):2137-48. PubMed ID: 19269290
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori infection in relation to E-cadherin gene promoter polymorphism and hypermethylation in sporadic gastric carcinomas.
Liu YC; Shen CY; Wu HS; Chan DC; Chen CJ; Yu JC; Yu CP; Harn HJ; Shyu RY; Shih YL; Hsieh CB; Hsu HM
World J Gastroenterol; 2005 Sep; 11(33):5174-9. PubMed ID: 16127748
[TBL] [Abstract][Full Text] [Related]
10. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
Sarrió D; Moreno-Bueno G; Hardisson D; Sánchez-Estévez C; Guo M; Herman JG; Gamallo C; Esteller M; Palacios J
Int J Cancer; 2003 Aug; 106(2):208-15. PubMed ID: 12800196
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.
Graziano F; Arduini F; Ruzzo A; Mandolesi A; Bearzi I; Silva R; Muretto P; Testa E; Mari D; Magnani M; Scartozzi M; Cascinu S
Ann Oncol; 2004 Mar; 15(3):489-92. PubMed ID: 14998854
[TBL] [Abstract][Full Text] [Related]
13. CDH1 gene promoter hypermethylation in gastric cancer: relationship to Goseki grading, microsatellite instability status, and EBV invasion.
Zazula M; Ferreira AM; Czopek JP; Kolodziejczyk P; Sinczak-Kuta A; Klimkowska A; Wojcik P; Okon K; Bialas M; Kulig J; Stachura J
Diagn Mol Pathol; 2006 Mar; 15(1):24-9. PubMed ID: 16531765
[TBL] [Abstract][Full Text] [Related]
14. [E-cadherin expression and CDH1 promoter methylation in sporadic and hereditary gastric cancer].
Li XJ; Zhao Y; Ren H
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):125-7. PubMed ID: 25613626
[TBL] [Abstract][Full Text] [Related]
15. [E-cadherin expression and CDH1 promoter methylation in sporadic and hereditary gastric cancer].
Li XJ; Zhao Y; Ren H
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):125-7. PubMed ID: 23353171
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
[TBL] [Abstract][Full Text] [Related]
17. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.
Tamura G; Yin J; Wang S; Fleisher AS; Zou T; Abraham JM; Kong D; Smolinski KN; Wilson KT; James SP; Silverberg SG; Nishizuka S; Terashima M; Motoyama T; Meltzer SJ
J Natl Cancer Inst; 2000 Apr; 92(7):569-73. PubMed ID: 10749913
[TBL] [Abstract][Full Text] [Related]
18. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas.
Matsumura T; Makino R; Mitamura K
Clin Cancer Res; 2001 Mar; 7(3):594-9. PubMed ID: 11297254
[TBL] [Abstract][Full Text] [Related]
19. Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients.
Yamada H; Shinmura K; Goto M; Iwaizumi M; Konno H; Kataoka H; Yamada M; Ozawa T; Tsuneyoshi T; Tanioka F; Sugimura H
Mol Cancer; 2009 Aug; 8():63. PubMed ID: 19671196
[TBL] [Abstract][Full Text] [Related]
20. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
